HIV infection--independently of classic risk factors--nearly tripled the risk of cardiovascular disease in a study of more than 2000 women in the US Veterans Aging Cohort Study . Higher heart disease risk with versus without HIV held true regardless of CD4 count. But women with a viral load below 500 copies did not have a higher cardiovascular disease risk than women without HIV, whereas women with a viral load above 500 copies did.
07 March 2014 | NATAP
Researchers advise reducing risk through diet, exercise, not smoking.
25 February 2014 | National Institutes of Health (press release)
MUMBAI: Hypertension or high blood pressure could be as devastating to global health as HIV. This is a warning spelt out in the International Journal of Epidemiology this week. Experts from the London School of Hygiene and Tropical Medicine have warned that the response of most governments and international aid agencies to hypertension is little better than the reaction of HIV\AIDS 20 years back - too little, too late.
05 February 2014 | Times of India
Ten-year stroke rate was almost 2 times higher in HIV-positive US men who have sex with men (MSM) than in HIV-negative MSM, and the Framingham Risk Score underestimated stroke risk in men with HIV.
03 February 2014 | International AIDS Society
The researchers found that almost half of the patients (47%) had some type of structural heart disease, usually left ventricular hypertrophy, left ventricular dysfunction, pulmonary hypertension and signs of right ventricle failure. Patients with a positive viral load displayed a significantly higher incidence of structural heart disease than those with an undetectable load - 75% as opposed to 43%.
17 December 2013 | Medical News Today
The HIV Medicine Association of the Infectious Diseases Society of America has updated its HIV care guidelines to reflect the fact that people with HIV are now living normal life spans, and their physicians need to focus on preventive care, including screening for high cholesterol, diabetes and osteoporosis.
14 November 2013 | Eurekalert Inf Dis
The Framingham model for global cardiovascular disease (CVD) risk may significantly underestimate the likelihood of CV events in HIV-infected patients, say researchers, who believe they have developed a better model, derived from the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
04 November 2013 | Medscape (requires free registration)
Researchers in Boston have intensely studied women, both HIV positive and negative, to better understand the interactions between their immune and cardiovascular systems. They have found that HIV-positive women were more likely to have more sticky deposits in their arteries called plaque, specifically non-calcified plaque (NCP).
27 September 2013 | CATIE
Rates of cardiac arrhythmias associated with methadone rose in the United States from 1997 to 2011, according to analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS). Taking methadone with antiretroviral therapy (ART) may pose a particular risk.
15 July 2013 | International AIDS Society
This issue of Research Initiative, Treatment Action (RITA!) carefully examines evidence from well over 100 studies on cardiovascular risk factors and the impact of individual and combined antiretrovirals on the heart.This RITA! also features an interview with the University of Wisconsin’s James Stein, perhaps the leading authority on cardiovascular disease in people with HIV. Stein offers frank and insightful answers to questions on cardiovascular risk, screening adults and children, the Framingham score, lipid targets, aspirin prophylaxis, and smoking.
20 June 2013 | RITA! / Center for AIDS Information and Advocacy